Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Nicolas Schweizer, CEO of Schweitzer Electronic, envisions a thriving future for the PCB industry in Europe.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Nicolas Schweizer, CEO of Schweitzer Electronic
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Gino Roger Joins Midland Exploration Inc. | Gino Roger - President,CEO & Director of Midland Exploration Inc.
00:10:00
Barton Gold: Driving Growth with Resource Expansion and Asset Monetization
00:10:00
Global Geosciences CEO Discusses Low-Cost Lithium-Boron Production at Rhyolite Ridge
00:10:00
IonuČ› Bindea Discusses Roca Industry’s Market Strategies in Exclusive Q&A | IonuČ› Bindea, CEO, ROCA Industry Holdingrock1 SA.
00:10:00
DLH CEO Zach Parker Emphasizes Diversity and Inclusion for Company Culture and Customer Value | Zachary Parker - President, CEO, and Board Director of DLH Holdings Corp.
00:10:00
Viorel Panait de la Comvex: Spotlight at Financial Intelligence's 2023 Capital Market Forum | Panait Viorel - CEO of Comvex
00:10:00
Emerging Markets Debt: 3 Ways We Are Differentiated | William Blair Investment Management
00:10:00
American Creek Resources: Breakthrough Resource Estimate at Treaty Creek
00:10:00
One Powerful Relationship,Boundless Opportunities|Stephen Dover|Chief Market Strategist, Head of Franklin Templeton Institute,Franklin Templeton Institute
00:10:00
KPI Mining Revolutionizes Mine Planning with AI-Based Stochastic Optimization
00:10:00
Blue Value Advisors: Your Guide from Business Assessment to Successful Exit
00:10:00
Teleborsa S.p.A. interviews Alessio Aceti, CEO of Sababa Security.